DAX24.114 +1,0%Est505.581 +0,9%MSCI World4.323 ±0,0%Top 10 Crypto16,20 -0,6%Nas22.755 +0,4%Bitcoin100.933 ±0,0%Euro1,1739 ±0,0%Öl65,56 +0,2%Gold3.872 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Siemens Energy ENER6Y Novo Nordisk A3EU6F Tesla A1CX3T Lufthansa 823212 Bayer BAY001 Wolfspeed A41JEH HENSOLDT HAG000 Plug Power A1JA81 Deutsche Telekom 555750 Alibaba A117ME Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX vor starker Eröffnung -- Asiens Börsen ziehen an -- VW mit durchwachsenem US-Absatz im dritten Quartal -- Elon Musks Vermögen knackt wichtige Marke -- Nordex, BVB im Fokus
Top News
China beschränkt angeblich Nutzung von Nokia- und Ericsson-Ausrüstung China beschränkt angeblich Nutzung von Nokia- und Ericsson-Ausrüstung
VINCI-Aktie: Eigene Aktien für bis zu 600 Millionen Euro sollen zurückgekauft werden VINCI-Aktie: Eigene Aktien für bis zu 600 Millionen Euro sollen zurückgekauft werden
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Börsenspiel Trader 2025: Jetzt mit dem Kennwort "finanzen.net" unserer Spielgruppe beitreten und ein Aktienpaket von finanzen.net zero gewinnen!

Illumina Aktie

Kaufen
Verkaufen
Illumina Aktien-Sparplan
87,10 EUR +0,77 EUR +0,89 %
FSE
102,26 USD -0,03 USD -0,03 %
nachbörslich
BTT
Illumina jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.12,44 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN927079

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS4523271090

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolILMN

Illumina Aktien News

DatumMeistgelesen
PR NewswireIllumina launches new business to accelerate technology and data-driven discovery
PR NewswireIllumina advances personalized cancer care with new pharma development partnerships
PR NewswireAlnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Wer­bungIllumina-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireIllumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireIllumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
PR NewswireNilesh Shah joins Illumina as Head of Region, AMEA
PR NewswireIllumina enhances flagship assay to accelerate access to comprehensive tumor profiling
PR NewswireIllumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025
PR NewswireIllumina named to TIME's World's Most Sustainable Companies list for the second consecutive year
PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
PR NewswireIllumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
PR Newswirelllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
PR NewswireIllumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
PR NewswireIllumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireIllumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
PR NewswireIllumina Reports Financial Results for First Quarter of Fiscal Year 2025
PR NewswireIllumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
PR NewswireIllumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
PR NewswireIllumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025
PR NewswireIllumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
PR NewswireAlliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
PR NewswireIllumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
PR NewswireIllumina transforms multiomic research with new technologies to unlock deeper understanding of biology
PR NewswireIllumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
PR NewswireIllumina unveils first-of-its-kind spatial transcriptomics technology
PR NewswireIllumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference
PR NewswireIllumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025
PR NewswireIllumina and NVIDIA collaborate to decode biology and propel precision health
PR NewswireIllumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples
PR NewswireIllumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025
PR NewswireIllumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
PR NewswireMacrogen Consortium win tender for National Bio Big Data Project
PR NewswireIllumina To Webcast Upcoming Investor Conference
PR NewswireSynaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
PR NewswireSynaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
PR NewswireIllumina announces expansion of TruSight Oncology portfolio

Illumina News

Illumina News: auf dieser Seite finden Sie alle Illumina News und Nachrichten zur Illumina Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Illumina News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Illumina News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.